Tarsus Pharmaceuticals, Inc.
TARS
Revenue
78.34M
▲11.93M▲17.96%
3 Months ChangeAssets
500.75M
▲123.76M▲32.83%
3 Months ChangeLiabilities
158.29M
▲5.84M▲3.83%
3 Months ChangeFree Cash Flow
-21.24M
▲16.72M▲44.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0001819790-24-000111
2024-08-08
Form 8-K
ID: 0001819790-24-000109
2024-06-18
Form 8-K
ID: 0001819790-24-000087
2024-05-08
Form 10-Q
ID: 0001819790-24-000063
2024-05-08
Form 8-K
ID: 0001819790-24-000062
2024-04-23
Form 8-K
ID: 0001819790-24-000050
2024-03-05
Form 8-K
ID: 0001819790-24-000024
2024-03-01
Form 8-K
ID: 0001193125-24-056209
2024-02-27
Form 8-K
ID: 0001819790-24-000015
2024-01-18
Form 8-K
ID: 0001819790-24-000006